EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access

Global prevalence of post-COVID-19 condition: a systematic review and meta-analysis of prospective evidence

Mohamed Kadry Taher, Talia Salzman, Allyson Banal, Kate Morissette, Francesca R Domingo, Angela M Cheung, Curtis L Cooper, Laura Boland, Alexandra M Zuckermann, Muhammad A Mullah, Claudie Laprise, Roberto Colonna und 8 weitere

Health Promotion and Chronic Disease Prevention in Canada · 2025

DOI: 10.24095/hpcdp.45.3.02 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Health Promotion and Chronic Disease Prevention in Canada, 2025. Verfasst von Mohamed Kadry Taher und 19 weiteren Autor:innen. Beteiligte Einrichtung: Evidence Synthesis and Knowledge Translation Unit, Centre for Surveillance and Applied Research, Health Promotion and Chronic Disease Prevention Bran…. Hauptthemen laut MEDLINE: COVID-19, Survivors. Die Arbeit wurde bisher 39-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

We investigated the prevalence of new or persistent manifestations experienced by COVID-19 survivors at 3 or more months after their initial infection, collectively known as post-COVID-19 condition (PCC).

Methods

We searched four electronic databases and major grey literature resources for prospective studies, systematic reviews, authoritative reports and population surveys. A random-effects meta-analysis pooled the prevalence data of 22 symptoms and outcomes. The GRADE approach was used to assess the certainty of evidence. PROSPERO CRD42021231476.

Results

Of 20 731 identified references, 194 met our inclusion criteria. These studies followed 483 531 individuals with confirmed COVID-19 diagnosis over periods of up to 2 years. Most focused on adults, nearly two-thirds were conducted in Europe and 63% were of high or moderate quality. The supplementary search identified 17 systematic reviews, five authoritative reports and four population surveys that reported on PCC prevalence. Our analysis revealed that more than half of COVID-19 survivors experienced one or more symptoms more than a year after their initial infection. The most common symptoms were fatiguedyspneamemory, sleep or concentration disturbances; depressionand pain. Limitation in returning to work was the most common outcome. Prevalence tended to be higher among females, individuals hospitalized during their initial infection and those who experienced severe COVID-19 illness.

Conclusion

PCC presents a significant health burden, affecting some groups more than others. This information will help inform health care system policies and services for people living with PCC and those caring for them.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SurvivorsHumansPrevalenceProspective StudiesSARS-CoV-2Global HealthFemalePost-Acute COVID-19 Syndrome

Stichwörter der Autor:innen

COVID-19 Long-HaulerCOVID-19 recoveryLong COVIDPASCPCClongterm effects of COVID-19post-COVID conditionpost-acute sequelae of COVID-19prevalenceprospective studiessystematic review

Autor:innen und Institutionen

  • Evidence Synthesis and Knowledge Translation Unit, Centre for Surveillance and Applied Research, Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, Ontario, Canada.
  • School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.
  • Department of Medicine and Joint Department of Medical Imaging, University Health Network and Sinai Health System, University of Toronto, Toronto, Ontario, Canada.
  • Toronto General Hospital Research Institute and Schroeder Arthritis Institute, Toronto, Ontario, Canada.
  • Department of Medicine, University of OttawaOttawa Hospital Research Institute, Ottawa, Ontario, Canada.
  • Infectious Disease and Vaccination Programs Branch, Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, Ontario, Canada.

Zitieren

APA

Taher, M. K., Salzman, T., Banal, A., Morissette, K., Domingo, F. R., Cheung, A. M., Cooper, C. L., Boland, L., Zuckermann, A. M., Mullah, M. A., Laprise, C., Colonna, R., Hashi, A., Rahman, P., Collins, E., Corrin, T., Waddell, L. A., Pagaduan, J. E., Ahmad, R., & Jaramillo Garcia, A. P. (2025). Global prevalence of post-COVID-19 condition: a systematic review and meta-analysis of prospective evidence. Health Promotion and Chronic Disease Prevention in Canada. https://doi.org/10.24095/hpcdp.45.3.02

Vancouver

Taher MK, Salzman T, Banal A, Morissette K, Domingo FR, Cheung AM, et al. Global prevalence of post-COVID-19 condition: a systematic review and meta-analysis of prospective evidence. Health Promotion and Chronic Disease Prevention in Canada. 2025. doi:10.24095/hpcdp.45.3.02

BibTeX
@article{Taher2025,
  author = {Taher, Mohamed Kadry and Salzman, Talia and Banal, Allyson and Morissette, Kate and Domingo, Francesca R and Cheung, Angela M and Cooper, Curtis L and Boland, Laura and Zuckermann, Alexandra M and Mullah, Muhammad A and Laprise, Claudie and Colonna, Roberto and Hashi, Ayan and Rahman, Prinon and Collins, Erin and Corrin, Tricia and Waddell, Lisa A and Pagaduan, Jason E and Ahmad, Rukshanda and Jaramillo Garcia, Alejandra P},
  title = {Global prevalence of post-COVID-19 condition: a systematic review and meta-analysis of prospective evidence},
  journal = {Health Promotion and Chronic Disease Prevention in Canada},
  year = {2025},
  doi = {10.24095/hpcdp.45.3.02}
}
Kostenlos starten →